Praziquantel has remained the drug of choice for schistosomiasis chemotherapy for almost
40 years. The pressing need to develop a new antischistosomal drug may necessitate …

Infections caused by parasitic helminths rank among the most prevalent infections of
humans and animals. Toxocariasis, caused by nematodes of the genus Toxocara, is one of …

Schistosomiasis affects million people and its control is widely dependent on a single drug,
praziquantel. Computational chemistry has led to the development of new tools that predict …

Schistosomiasis is one of the most important parasitic infections in terms of its negative
effects on public health and economics. Since praziquantel is currently the only drug …

Praziquantel is the only available drug to treat schistosomiasis, a parasitic disease that
currently infects more than 240 million people globally. Due to increasing concerns about …

Schistosomiasis is a widespread human parasitic disease currently affecting over 200
million people, particularly in poor communities. Chemotherapy for schistosomiasis relies …

Background Treatment and control of schistosomiasis, one of the most insidious and serious
parasitic diseases, depend almost entirely on a single drug, praziquantel. Since the funding …

The treatment and control of schistosomiasis, a neglected disease that affects more than 200
million people worldwide, rely on the use of a single drug, praziquantel. A vaccine has yet to …

Schistosomiasis, a parasitic disease caused by the blood fluke of the genus Schistosoma,
affects over 230 million people, especially in developing countries. Despite the significant …

The intravascular parasitic worm Schistosoma mansoni is a causative agent of
schistosomiasis, a disease of great global public health significance. Praziquantel is the only …